Citation Impact
Citing Papers
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 StandoutScience
Amyotrophic Lateral Sclerosis
2017
Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis
2018
Genetic factors in end-stage renal disease
2005
Parkinson's disease
2021 Standout
The epidemiology of amyotrophic lateral sclerosis
2016
Gene therapy for neurological disorders: progress and prospects
2018
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
2011 Standout
A genome scan for diabetic nephropathy in African Americans
2004
The glymphatic pathway in neurological disorders
2018 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Amyotrophic lateral sclerosis
2017
Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia
2017
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Decoding ALS: from genes to mechanism
2016 StandoutNature
Targeting Oxidative Stress in Central Nervous System Disorders
2016
The Relationships Between Plasma and Red Cell Vitamin B2 and B6 Concentrations and the Systemic and Local Inflammatory Responses in Patients With Colorectal Cancer
2012
The Missing Diversity in Human Genetic Studies
2019 Standout
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
2018
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD
2018
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
2018
Is Antioxidant and n–3 Supplementation Able to Improve Functional Status in Poststroke Patients? Results from the Nutristroke Trial
2009
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Structure, function and disease relevance of Omega-class glutathione transferases
2016
Hydrogen sulphide and its therapeutic potential
2007 Standout
Negative regulation of β-adrenergic function by hydrogen sulphide in the rat hearts
2008
MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis
2014
Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus
1995
Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol
2004
In vivo PET imaging of neuroinflammation in Alzheimer’s disease
2017
GBA1-associated parkinsonism: new insights and therapeutic opportunities
2019
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
2006
Ethnic Disparities in Diabetic Complications in an Insured Population
2002 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Erratum: Gene therapy for neurological disorders: progress and prospects
2018
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
The altered autophagy mediated by TFEB in animal and cell models of amyotrophic lateral sclerosis.
2015
Business Artificial Intelligence
2021 Standout
Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications
2017
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
2009 Standout
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion
2018
Works of Nazem Atassi being referenced
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
2018
Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28
2015
A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis
2010
Neuroprotective agents target molecular mechanisms of disease in ALS
2014
Amyotrophic lateral sclerosis: Analysis of ALS cases in a predominantly admixed population of Ecuador
2013
Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
2014
Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
1995
Pre‐morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
2015
Transplantation of spinal cord–derived neural stem cells for ALS
2016
Inflammation, Homocysteine, and Vitamin B6 Status After Ischemic Stroke
2003